Washington Weekly Podcast: Government shutdown, U.S. Drug Pricing
From UBS On-Air: In the Now by Client Strategy Office
October 1, 2025 · 9 min
About this episode
The episode discusses the impact of the U.S. government shutdown and recent announcements regarding drug pricing.
As the U.S. government has entered a shutdown, Shane drops by to explain the scope of impact, along with next steps with respect to negotiations. Plus, thoughts on yesterday’s Oval Office announcement related to drug pricing. Featured is Shane Lieberman, Senior Governmental Affairs Advisors, Government Affairs US. Host: Daniel Cassidy
People in this episode
Host: Daniel Cassidy
Guest: Shane Lieberman
Topics covered
- government shutdown
- drug pricing
- U.S. politics
- negotiations
- government affairs
Keywords
- government shutdown
- drug pricing
- Shane Lieberman
- negotiations
- U.S. politics
Mentioned in this episode
Products: U.S. Drug Pricing
Places: U.S.
More episodes of UBS On-Air: In the Now
- House View Daily | Volatility in AI and tech do not derail the investment thesis · June 12, 2026
- House View Daily | Markets should overcome near-term headwinds · June 11, 2026
- House View Daily | Renewed tech selling leads markets lower · June 10, 2026
- House View Daily | Health care offers more than a defensive role in portfolios · June 9, 2026
- House View Daily | Equities fall on tech pressures · June 8, 2026
- Washington Weekly Podcast: Davos takeaways, Greenland, Government shutdown · January 23, 2026 · 11 min
Explore listener stats, chart rankings, contacts and more on the UBS On-Air: In the Now podcast page.